COVID-19 Trials in Long Beach, United States
Conditions / COVID-19 / Long Beach, United States
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
36 total trials for this combination
Showing top 10 of 36 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06178991 | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. | COMPLETED | PHASE3 |
| NCT05605093 | Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) | TERMINATED | PHASE3 |
| NCT05780424 | BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | COMPLETED | PHASE3 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | COMPLETED | PHASE1/PHASE2 |
| NCT05822583 | Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial | COMPLETED | PHASE4 |
| NCT04955626 | To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. | COMPLETED | PHASE3 |
| NCT05780281 | VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | COMPLETED | PHASE3 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | COMPLETED | PHASE2/PHASE3 |
| NCT05780437 | AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | COMPLETED | PHASE3 |
| NCT05815498 | A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 | COMPLETED | — |